Challenges in Clinical Practice of Post-Stroke Cognitive Impairment

doi:10.3969/j.issn.1673-5765.2023.11.001

Abstract

Abstract: Post-stroke cognitive impairment (PSCI) refers to any severity of cognitive impairment within six months after a stroke. Because stroke usually leads to aphasia, apraxia and agnosia, neuropsychological assessment of PSCI should be different from general assessment battery, and appropriate examination should be chosen to avoid overestimation of the severity of cognitive impairment. The etiology of PSCI is complex and needs to be comprehensively considered. In addition to the etiology of stroke, the background of brain pathology related to brain reserve should also be considered, such as cerebral small vessel disease and neurodegene-rative diseases. For the treatment of PSCI, etiological and symptomatic treatment, drug and non-drug treatment are very important.

Key words: Post-stroke cognitive impairment; Neuropsychological assessment; Mixed cognitive impairment

摘要： 卒中后认知障碍（post-stroke cognitive impairment，PSCI）是指在卒中事件后6个月内发生的任何程度的认知损害。因为卒中患者常出现失语、失用和失认，所以PSCI的神经心理学评估不同于一般的成套评估，需要选取合适的测验，否则容易高估患者的认知损害程度。PSCI病因具有复杂性，需要全面考虑，除了卒中的病因之外，还需要考虑与脑储备相关的脑病理背景，如脑小血管病和神经系统变性病。对于PSCI的治疗，病因及对症治疗、药物和非药物治疗都很重要。

关键词: 卒中后认知障碍; 神经心理学评估; 混合性认知障碍

LIU Caiyan, CHENG Anqi, XU Weihai. Challenges in Clinical Practice of Post-Stroke Cognitive Impairment [J]. Chinese Journal of Stroke, 2023, 18(11): 1215-1219.

刘彩燕, 程安琪, 徐蔚海. 卒中后认知障碍临床诊疗实践面临的挑战[J]. 中国卒中杂志, 2023, 18(11): 1215-1219.

References

[1] ROST N S，BRODTMANN A，PASE M P，et al. Post-stroke cognitive impairment and dementia[J]. Circ Res，2022，130（8）：1252-1271.
[2] SKROBOT O A，O'BRIEN J，BLACK S，et al. The vascular impairment of cognition classification consensus study[J]. Alzheimers Dement，2017，13（6）：624-633.
[3] PINTER D，ENZINGER C，GATTRINGER T，et al. Prevalence and short-term changes of cognitive dysfunction in young ischaemic stroke patients[J]. Eur J Neurol，2019，26（5）：727-732.
[4] HACHINSKI V，IADECOLA C，PETERSEN R C，et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards[J]. Stroke，2006，37（9）：2220-2241.
[5] QUINN T J，RICHARD E，TEUSCHL Y，et al. European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment[J]. Eur J Neurol，2021，28（12）：3883-3920.
[6] LEES R A，HENDRY BA K，BROOMFIELD N，et al. Cognitive assessment in stroke：feasibility and test properties using differing approaches to scoring of incomplete items[J]. Int J Geriatr Psychiatry，2017，32（10）：1072-1078.
[7] DEMEYERE N，RIDDOCH M J，SLAVKOVA E D，et al. The Oxford cognitive screen（OCS）：validation of a stroke-specific short cognitive screening tool[J]. Psychol Assess，2015，27（3）：883-894.
[8] TOWFIGHI A，OVBIAGELE B，EL HUSSEINI N，et al. Poststroke depression：a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke，2017，48（2）：e30-e43[2023-10-22]. https://doi.org/10.1161/STR.0000000000000113.
[9] KAPOOR A，LANCTÔT K L，BAYLEY M，et al. "Good outcome" isn't good enough：cognitive impairment，depressive symptoms，and social restrictions in physically recovered stroke patients[J]. Stroke，2017，48（6）：1688-1690.
[10] RAFSTEN L，DANIELSSON A，SUNNERHAGEN K S. Anxiety after stroke：a systematic review and meta-analysis[J]. J Rehabil Med，2018，50（9）：769-778.
[11] EL HUSSEINI N，KATZAN I L，ROST N S，et al. Cognitive impairment after ischemic and hemorrhagic stroke：a scientific statement from the American Heart Association/American Stroke Association[J/OL]. Stroke，2023，54（6）：e272-e291[2023-10-22]. https://doi.org/10.1161/STR.0000000000000430.
[12] MIJAJLOVIĆ M D，PAVLOVIĆ A，BRAININ M，et al. Post-stroke dementia-a comprehensive review[J/OL]. BMC Med，2017，15（1）：11[2023-10-22]. https://doi.org/10.1186/s12916-017-0779-7.
[13] RASQUIN S M，LODDER J，VERHEY F R. Predictors of reversible mild cognitive impairment after stroke：a 2-year follow-up study[J/OL]. J Neurol Sci，2005，229/230：21-25[2023-10-22]. https://doi.org/10.1016/j.jns.2004.11.015.
[14] DOUIRI A，RUDD A G，WOLFE C D. Prevalence of poststroke cognitive impairment：South London stroke register 1995-2010[J]. Stroke，2013，44（1）：138-145.
[15] KNOPMAN D S，DEKOSKY S T，CUMMINGS J L，et al. Practice parameter：diagnosis of dementia（an evidence-based review）. Report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology，2001，56（9）：1143-1153.
[16] AMIN AL OLAMA A，WASON J M S，TULADHAR A M，et al. Simple MRI score aids prediction of dementia in cerebral small vessel disease[J/OL]. Neurology，2020，94（12）：e1294-e1302[2023-10-22]. https://doi.org/10.1212/WNL.0000000000009141.
[17] KAPASI A，DECARLI C，SCHNEIDER J A. Impact of multiple pathologies on the threshold for clinically overt dementia[J]. Acta Neuropathol，2017，134（2）：171-186.
[18] WEAVER N A，KUIJF H J，ABEN H P，et al. Strategic infarct locations for post-stroke cognitive impairment：a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts[J]. Lancet Neurol，2021，20（6）：448-459.
[19] MOULIN S，LABREUCHE J，BOMBOIS S，et al. Dementia risk after spontaneous intracerebral haemorrhage：a prospective cohort study[J]. Lancet Neurol，2016，15（8）：820-829.
[20] BIFFI A，BAILEY D，ANDERSON C D，et al. Risk factors associated with early vs delayed dementia after intracerebral hemorrhage[J]. JAMA Neurol，2016，73（8）：969-976.
[21] SMITH E E. Cerebral amyloid angiopathy as a cause of neurodegeneration[J]. J Neurochem，2018，144（5）：651-658.
[22] STIENEN M N，SMOLL N R，WEISSHAUPT R，et al. Delayed cerebral ischemia predicts neurocognitive impairment following aneurysmal subarachnoid hemorrhage[J/OL]. World Neurosurg，2014，82（5）：e599-e605[2023-10-22]. https://doi.org/10.1016/j.wneu.2014.05.011.
[23] PENDLEBURY S T，ROTHWELL P M. Prevalence，incidence，and factors associated with pre-stroke and post-stroke dementia：a systematic review and meta-analysis[J]. Lancet Neurol，2009，8（11）：1006-1018.
[24] PENDLEBURY S T，ROTHWELL P M，Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke：analysis of the population-based Oxford vascular study[J]. Lancet Neurol，2019，18（3）：248-258.
[25] MOK V C，LAM B Y，WONG A，et al. Early-onset and delayed-onset poststroke dementia-revisiting the mechanisms[J]. Nat Rev Neurol，2017，13（3）：148-159.
[26] LO J W，CRAWFORD J D，SAMARAS K，et al. Association of prediabetes and type 2 diabetes with cognitive function after stroke：a STROKOG collaboration study[J]. Stroke，2020，51（6）：1640-1646.
[27] NGANDU T，LEHTISALO J，KORKKI S，et al. The effect of adherence on cognition in a multidomain lifestyle intervention（FINGER）[J]. Alzheimers Dement，2022，18（7）：1325-1334.
[28] BATTLE C E，ABDUL-RAHIM A H，SHENKIN S D，et al. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments：a network meta-analysis[J/OL]. Cochrane Database Syst Rev，2021，2（2）：CD013306[2023-10-22]. https://doi.org/10.1002/14651858.CD013306.pub2.
[29] MCSHANE R，WESTBY M J，ROBERTS E，et al. Memantine for dementia[J/OL]. Cochrane Database Syst Rev，2019，3（3）：CD003154[2023-10-22]. https://doi.org/10.1002/14651858.CD003154.pub6.
[30] GORGORAPTIS N，MAH Y H，MACHNER B，et al. The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke[J/OL]. Brain，2012，135（Pt 8）：2478-2491[2023-10-22]. https://doi.org/10.1093/brain/aws154.
[31] BARTOLO M，ZUCCHELLA C，CAPONE A，et al. An explorative study regarding the effect of l-deprenyl on cognitive and functional recovery in patients after stroke[J]. J Neurol Sci，2015，349（1/2）：117-123.
[32] ALVAREZ-SABÍN J，ORTEGA G，JACAS C，et al. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment[J]. Cerebrovasc Dis，2013，35（2）：146-154.
[33] WOODHOUSE L，SCUTT P，KRISHNAN K，et al. Effect of hyperacute administration（within 6 hours）of transdermal glyceryl trinitrate，a nitric oxide donor，on outcome after stroke：subgroup analysis of the efficacy of nitric oxide in stroke（ENOS）trial[J]. Stroke，2015，46（11）：3194-3201.
[34] MCKEE A C，MEZ J，ABDOLMOHAMMADI B，et al. Neuropathologic and clinical findings in young contact sport athletes exposed to repetitive head impacts[J]. JAMA Neurol，2023，80（10）：1037-1050.
[35] SHI J，WEI M Q，NI J N，et al. Tianzhi granule improves cognition and BPSD of vascular dementia：a randomized controlled trial[J/OL]. J Transl Med，2020，18（1）：76[2023-10-22]. https://doi.org/10.1186/s12967-020-02232-z.
[36] GIBSON E，KOH C L，EAMES S，et al. Occupational therapy for cognitive impairment in stroke patients[J/OL]. Cochrane Database Syst Rev，2022，3（3）：CD006430[2023-10-22]. https://doi.org/10.1002/14651858.CD006430.pub3.
[37] OH Y B，KIM G W，HAN K S，et al. Efficacy of virtual reality combined with real instrument training for patients with stroke：a randomized controlled trial[J]. Arch Phys Med Rehabil，2019，100（8）：1400-1408.
[38] TANG Y，XING Y，ZHU Z D，et al. The effects of 7-week cognitive training in patients with vascular cognitive impairment，no dementia（the Cog-VACCINE study）：a randomized controlled trial[J]. Alzheimers Dement，2019，15（5）：605-614.
[39] KO M H，YOON J Y，JO Y J，et al. Home-based transcranial direct current stimulation to enhance cognition in stroke：randomized controlled trial[J]. Stroke，2022，53（10）：2992-3001.
[40] ZHAO W B，ZHANG J，SADOWSKY M G，et al. Remote ischaemic conditioning for preventing and treating ischaemic stroke[J/OL]. Cochrane Database Syst Rev，2018，7（7）：CD012503[2023-10-22]. https://doi.org/10.1002/14651858.CD012503.pub2.
[41] SU X T，SUN N，ZHANG N，et al. Effectiveness and safety of acupuncture for vascular cognitive impairment：a systematic review and meta-analysis[J/OL]. Front Aging Neurosci，2021，13：692508[2023-10-22]. https://doi.org/10.3389/fnagi.2021.692508.